---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-323298"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:46:42.227888+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics Announces Departure of Chief Legal Officer Jason Carter

## Summary
- Jason Carter will cease to be Chief Legal Officer of Vera Therapeutics, effective December 24, 2025.
- The departure was announced on December 16, 2025, and filed on Form 8-K.
- No reason for the departure was disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-25-323298
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312525323298/0001193125-25-323298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312525323298/d26538d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-323298
- JSON: https://secwatch.observer/filing/0001193125-25-323298.json
- Plain text: https://secwatch.observer/filing/0001193125-25-323298.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.